The impact of Covid-19 restrictions on depressive symptoms in low-risk and high-risk pregnant women: a cross-sectional study before and during pandemic.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
08 Mar 2022
Historique:
received: 10 05 2021
accepted: 03 02 2022
entrez: 9 3 2022
pubmed: 10 3 2022
medline: 24 3 2022
Statut: epublish

Résumé

The COVID-19 social restrictions have increased the risk for depression compared to the previous period in Italian women with Low-Risk Pregnancy (LRP). lLess is known about the impact of COVID-19 restrictions on High-Risk Pregnancy (HRP). This study aimed: 1) to explore levels of depression in women who become pregnant before and during COVID-19 pandemic, distinguishing between LRP and HRP; 2) to analyze the impact of COVID-19 restrictions on pregnancy experience in LRP and HRP. A before-during COVID-19 pandemic cross-sectional study was carried out on 155 pregnant women (Mean age = 34.18), between 23 and 32 weeks of gestation. 77 women were recruited before COVID-19 pandemic (51.9% LRP; 48.1% HRP) and 78 women were recruited during COVID-19 pandemic (51.3% LRP; 48.7% HRP). HRP group was enrolled during hospitalization for high-risk pregnancy. Participants filled out Edinburgh Postnatal Depression Scale. Moreover, only COVID-19 group answered an open-ended question about the impact of restriction on pregnancy experience. HRP women reported higher levels of depressive symptoms than LRP. No difference emerged for COVID (before/during) but an interaction effect between COVID-19 and obstetric condition was found. The qualitative results showed the impact of restrictions on emotions and concerns. Respect to the previous period, LRP women during COVID-19 presented an increased risk for depressive symptoms than HRP. The HRP women during COVID-19 seemed to use hospitalization as a resource to find a social support network with other pregnant women and to be reassured on the clinical ongoing of pregnancy.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 social restrictions have increased the risk for depression compared to the previous period in Italian women with Low-Risk Pregnancy (LRP). lLess is known about the impact of COVID-19 restrictions on High-Risk Pregnancy (HRP). This study aimed: 1) to explore levels of depression in women who become pregnant before and during COVID-19 pandemic, distinguishing between LRP and HRP; 2) to analyze the impact of COVID-19 restrictions on pregnancy experience in LRP and HRP.
METHODS METHODS
A before-during COVID-19 pandemic cross-sectional study was carried out on 155 pregnant women (Mean age = 34.18), between 23 and 32 weeks of gestation. 77 women were recruited before COVID-19 pandemic (51.9% LRP; 48.1% HRP) and 78 women were recruited during COVID-19 pandemic (51.3% LRP; 48.7% HRP). HRP group was enrolled during hospitalization for high-risk pregnancy. Participants filled out Edinburgh Postnatal Depression Scale. Moreover, only COVID-19 group answered an open-ended question about the impact of restriction on pregnancy experience.
RESULTS RESULTS
HRP women reported higher levels of depressive symptoms than LRP. No difference emerged for COVID (before/during) but an interaction effect between COVID-19 and obstetric condition was found. The qualitative results showed the impact of restrictions on emotions and concerns.
CONCLUSION CONCLUSIONS
Respect to the previous period, LRP women during COVID-19 presented an increased risk for depressive symptoms than HRP. The HRP women during COVID-19 seemed to use hospitalization as a resource to find a social support network with other pregnant women and to be reassured on the clinical ongoing of pregnancy.

Identifiants

pubmed: 35260098
doi: 10.1186/s12884-022-04515-3
pii: 10.1186/s12884-022-04515-3
pmc: PMC8902730
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191

Informations de copyright

© 2022. The Author(s).

Références

J Matern Fetal Neonatal Med. 2018 Apr;31(7):919-925
pubmed: 28277908
Arch Acad Emerg Med. 2020 Mar 16;8(1):e21
pubmed: 32185371
J Clin Med. 2020 Jul 31;9(8):
pubmed: 32751804
J Affect Disord. 1999 May;53(2):137-41
pubmed: 10360408
J Affect Disord. 2020 Dec 1;277:5-13
pubmed: 32777604
J Matern Fetal Neonatal Med. 2016 Mar;29(5):771-6
pubmed: 25747945
J Fam Plann Reprod Health Care. 2005 Jan;31(1):40-3
pubmed: 15720849
Obstet Gynecol. 2013 Nov;122(5):957-965
pubmed: 24104771
Women Birth. 2021 Jul;34(4):335-343
pubmed: 32684343
J Perinat Med. 2020 Nov 26;48(9):965-970
pubmed: 32887191
J Pregnancy Child Health. 2017 Feb;4(1):
pubmed: 28702506
Nurs Health Sci. 2010 Jun;12(2):198-204
pubmed: 20602692
J Matern Fetal Neonatal Med. 2022 Jan;35(2):205-211
pubmed: 32419558
Gen Hosp Psychiatry. 2013 Mar-Apr;35(2):112-6
pubmed: 23265951
Int J Gynaecol Obstet. 2020 Oct;151(1):146-147
pubmed: 32620037
NCHS Data Brief. 2018 Jun;(312):1-8
pubmed: 30044213
QJM. 2020 Jun 22;:
pubmed: 32569360
BMC Pregnancy Childbirth. 2020 Nov 18;20(1):703
pubmed: 33208115
Arch Gen Psychiatry. 2010 Oct;67(10):1012-24
pubmed: 20921117
Arch Womens Ment Health. 2020 Dec;23(6):783-786
pubmed: 33215247
Arch Womens Ment Health. 2014 Feb;17(1):49-56
pubmed: 24022743
J Affect Disord. 2015 May 1;176:95-105
pubmed: 25704562
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Sci Rep. 2020 Dec 31;10(1):22457
pubmed: 33384427
Int J Gynaecol Obstet. 2020 Aug;150(2):184-188
pubmed: 32474910
Front Psychol. 2020 Oct 26;11:567155
pubmed: 33192847
Am J Mens Health. 2017 Jul;11(4):880-887
pubmed: 27885145
BMJ. 2004 Sep 18;329(7467):675-8
pubmed: 15374920

Auteurs

Martina Smorti (M)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Via Savi 10, 56126, Pisa, Italy. martina.smorti@unipi.it.

Angelo Gemignani (A)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Via Savi 10, 56126, Pisa, Italy.

Lucia Bonassi (L)

Department of Mental Health, ASST Bergamo-Est, Seriate, Italy.

Giulia Mauri (G)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Via Savi 10, 56126, Pisa, Italy.

Alessia Carducci (A)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Via Savi 10, 56126, Pisa, Italy.

Chiara Ionio (C)

Catholic University of Milano, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH